Pathophysiology of coronary vascular remodeling: relationship with traditional risk factors for coronary artery

Rojina Pant1, Rajinder Marok, Lloyd W Klein

  • 1From the *Department of Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois; and †Department of Internal Medicine / Cardiology Section, Advocate Illinois Masonic Medical Center and Rush Medical College, Chicago, Illinois.

Cardiology in Review
|July 23, 2013
PubMed

Insights

Cardiovascular risk factors like endothelial dysfunction and inflammation drive vascular remodeling. Understanding these mechanisms, including plaque composition and matrix metalloproteinases, is key for future therapies.

Area of Science:

  • Cardiovascular biology and pathology.

Background:

  • Vascular remodeling is a significant factor in cardiovascular disease progression.
  • The interplay between cardiovascular risk factors and vascular remodeling is an emerging area of research.

Purpose of the Study:

  • To elucidate the mechanisms by which cardiovascular risk factors induce vascular remodeling.
  • To explore the role of plaque composition and specific molecular factors in directing remodeling.
  • To understand how different risk factors contribute to positive, negative, or constrictive remodeling.

Main Methods:

  • Review of existing literature on cardiovascular risk factors and vascular remodeling.
  • Analysis of mechanisms including endothelial dysfunction, lipoprotein alterations, inflammation, and platelet activation.
  • Examination of the role of matrix metalloproteinases and advanced glycation end-products.

Main Results:

  • Cardiovascular risk factors initiate vascular remodeling through endothelial dysfunction, inflammation, and lipoprotein changes.
  • Plaque calcification influences remodeling direction, with extensive calcification favoring constrictive remodeling.
  • Specific factors like advanced glycation end-products in diabetes promote negative remodeling, while hypertension can lead to hypertrophic or eutrophic remodeling.

Conclusions:

  • Vascular remodeling is a complex process influenced by multiple cardiovascular risk factors.
  • Understanding these mechanisms, including the impact of dyslipidemia, smoking, and aging, is crucial for clinical applications.
  • This knowledge can guide future therapeutic strategies for cardiovascular diseases.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...